Perturbed gut microbiota and serum metabolites are associated with progressive renal fibrosis

Perturbed gut microbiota and serum metabolites are associated with progressive renal fibrosis

IntroductionThe intricate pathogenesis of renal fibrosis necessitates identifying biomarkers at various stages to facilitate targeted therapeutic interventions, which would enhance patient survival rates and significantly improve prognosis.MethodsWe investigated the changes in gut microbiota and ser...

Full description

Saved in:

Bibliographic Details
Main Authors:	Run-Xi Wang, Hong-Bing Zhou, Jia-Xing Gao, Xing-Hua Li, Wan-Fu Bai, Jia Wang, Ying-Chun Bai, Li-Ya Fan, Hong Chang, Song-Li Shi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Medicine
Subjects:	chronic kidney disease renal fibrosis disease progression oxidative stress inflammation biochemical markers
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1489100/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review
by: Ignacio Español Montero, et al.
Published: (2025-06-01)

Concurrent nonalcoholic fatty liver disease may decrease liver fibrosis severity in patients with primary biliary cholangitis
by: Wenhui Ren, et al.
Published: (2025-07-01)

Noninvasive grading of renal interstitial fibrosis and prediction of annual renal function loss in chronic kidney disease: the optimal solution of seven MR diffusion models
by: Guanjie Yuan, et al.
Published: (2025-12-01)

Predicting biomarkers of progressive pulmonary fibrosis: morphological, cytokine profile, and clinical portrait
by: Nicol Bernardinello, et al.
Published: (2025-06-01)

A bibliometric analysis of global research status and trends in irritable bowel syndrome and gut microbiota metabolites
by: Shi-Ran Wang, et al.
Published: (2025-08-01)

Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2015-05-01)

MicroRNAs as fibrosis markers in patients with hypersensitivity pneumonitis
by: G. S. Shepelkova, et al.
Published: (2024-04-01)

The patient journey and burden of disease in progressive pulmonary fibrosis in Japan: a cross-sectional survey
by: Yuko Kaneko, et al.
Published: (2025-04-01)

Effect of WISP-1 on fibrosis of renal tubular epithelial cell in rats with renal fibrosis
by: YANG Ermei, XIA Weiqing, SONG Pei, YAN Jia
Published: (2025-04-01)

Cartilage destruction in rheumatoid arthritis, its association with functional impairments
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01)

Systemic inflammation is associated with myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy
by: Xinli Guo, et al.
Published: (2025-02-01)

SOX9: a key transcriptional regulator in organ fibrosis
by: Yishuo Li, et al.
Published: (2025-02-01)

THE COURSE OF HEPATITIS C INFECTION AND RESPONSE TO ANTI-VIRAL THERAPY IN PATIENTS WITH THALASSEMIA MAJOR AND HEPATITIS C INFECTION: A LONGITUDINAL, PROSPECTIVE STUDY.
by: Sanaa Kamal, et al.
Published: (2019-10-01)

One case of immunoglobulin 4-related retroperitoneal fibrosis characterized by ureteral obstruction
by: Zhang Xing-wei, et al.
Published: (2025-02-01)

One case of immunoglobulin 4-related retroperitoneal fibrosis characterized by ureteral obstruction
by: Zhang Xing-wei, et al.
Published: (2025-02-01)

Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
by: Zhifeng Gao, et al.
Published: (2025-01-01)

Integrating Radiomics Signature into Clinical Pathway for Patients with Progressive Pulmonary Fibrosis
by: Giacomo Sica, et al.
Published: (2025-01-01)

Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary FibrosisTake-Home Points
by: Steven D. Nathan, MD, et al.
Published: (2025-06-01)

Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study
by: A. Denis, et al.
Published: (2025-05-01)

MRI findings of confluent hepatic fibrosis caused by different etiologies
by: Dan Yu, et al.
Published: (2025-07-01)

The mediating effect of stigma on the relationship between fear of disease progression and social alienation in patients with haematological malignancies
by: Dan Shi, et al.
Published: (2024-12-01)

Clustering-aided prediction of outcomes in patients with idiopathic pulmonary fibrosis
by: Lijun Wang, et al.
Published: (2024-10-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Assessment of Probability of Pulmonary Fibrosis Progression in Patients with Interstitial Lung Diseases to Determine Further Treatment Tactics
by: A. A. Lukashevich, et al.
Published: (2024-07-01)

Peripheral and pulmonary telomere lengths in patients with non-idiopathic pulmonary fibrosis interstitial lung diseases
by: Yujie Shi, et al.
Published: (2025-08-01)

Inhibition of Matrix Metalloproteinase-7 Attenuates Subpleural Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease
by: Li Xiong, et al.
Published: (2025-06-01)

Swine Flu Progressive Pulmonary Fibrosis – Clinical Manifestation and Morphology of Explanted Lungs
by: Shirish Sahebrao Chandanwale, et al.
Published: (2025-04-01)

The alternations of gut microbiota in diabetic kidney disease: insights from a triple comparative cohort
by: Mengqi Wu, et al.
Published: (2025-06-01)

Analytical complex of biochemical markers for preclinical diagnosis and prevention of cardiovascular diseases
by: N. G. Gumanova
Published: (2019-11-01)

The relationship of epicardial obesity and levels of cardiac fibrosis markers
by: O. V. Gritsenko, et al.
Published: (2019-05-01)

Advancements in the non-invasive diagnosis of renal fibrosis
by: Tingting Yuan, et al.
Published: (2025-07-01)

Predictors of myocardial fibrosis and loss of epicardial adipose tissue volume in the long-term period after myocardial infarction
by: O. L. Barbarash, et al.
Published: (2020-03-01)

Expression and clinical significance of Sonic hedgehog in renal interstitial fibrosis of patients with diabetic kidney disease
by: HOU Shi-hui, et al.
Published: (2017-01-01)

Role of inflammation-related genes as prognostic biomarkers and mechanistic implications in idiopathic pulmonary fibrosis
by: Bing Bai, et al.
Published: (2025-06-01)

Effects of adenosine and dipyridamole on serum levels of some biochemical markers in rabbits: Running title: Biochemical effects of adenosine and dipyridamole
by: Taghreed Hazem Saber Alfakje, et al.
Published: (2022-12-01)

Association between alcohol consumption and hepatic fibrosis in Chinese adult males with metabolic dysfunction-associated steatotic liver disease
by: Mao Li, et al.
Published: (2025-04-01)

Interstitial lung diseases: a view on the problem
by: O. G. Sych, et al.
Published: (2025-06-01)

The systemic inflammation markers as potential predictors of disease progression and survival time in amyotrophic lateral sclerosis
by: Ye Hong, et al.
Published: (2025-03-01)

Early diagnosis of myocardial fibrosis in patients with epicardial obesity
by: O. V. Gritsenko, et al.
Published: (2021-04-01)

Perturbations in gut microbiota composition in patients with autoimmune neurological diseases: a systematic review and meta-analysis
by: Xiaolin Deng, et al.
Published: (2025-02-01)